Valneva SE (VALN)
7.52
+0.10
(+1.35%)
USD |
NASDAQ |
May 13, 11:14
Valneva Profit Margin (Quarterly): -76.75% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -76.75% |
| September 30, 2023 | -89.90% |
| June 30, 2023 | -42.05% |
| March 31, 2023 | -54.10% |
| December 31, 2022 | -39.68% |
| September 30, 2022 | 46.22% |
| June 30, 2022 | -203.8% |
| March 31, 2022 | -119.2% |
| December 31, 2021 | 62.00% |
| September 30, 2021 | -713.9% |
| June 30, 2021 | -241.7% |
| March 31, 2021 | -119.3% |
| December 31, 2020 | -4.00% |
| September 30, 2020 | -335.4% |
| June 30, 2020 | -192.4% |
| March 31, 2020 | -3.49% |
| December 31, 2019 | 1.54% |
| September 30, 2019 | -0.12% |
| June 30, 2019 | -36.91% |
| March 31, 2019 | 13.92% |
| December 31, 2018 | 18.78% |
| September 30, 2018 | -15.80% |
| June 30, 2018 | -6.14% |
| Date | Value |
|---|---|
| March 31, 2018 | 4.54% |
| December 31, 2017 | -12.71% |
| September 30, 2017 | -15.31% |
| June 30, 2017 | -10.64% |
| March 31, 2017 | -5.83% |
| December 31, 2016 | -10.44% |
| September 30, 2016 | -38.09% |
| June 30, 2016 | -133.0% |
| March 31, 2016 | -21.21% |
| December 31, 2015 | -78.28% |
| September 30, 2015 | -25.56% |
| June 30, 2015 | -47.58% |
| March 31, 2015 | 52.61% |
| December 31, 2014 | -100.2% |
| September 30, 2014 | -23.19% |
| June 30, 2014 | -62.81% |
| March 31, 2014 | -113.2% |
| December 31, 2013 | -67.90% |
| September 30, 2013 | -72.10% |
| June 30, 2013 | -79.44% |
| March 31, 2013 | -345.9% |
| December 31, 2012 | -548.6% |
| September 30, 2012 | -235.3% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-713.9%
Minimum
Sep 2021
62.00%
Maximum
Dec 2021
-113.8%
Average
-54.10%
Median
Mar 2023
Profit Margin (Quarterly) Benchmarks
| DBV Technologies SA | -- |
| Cellectis SA | -15.15K% |
| PHAXIAM Therapeutics SA (DELISTED) | -- |
| Genfit SA | -- |
| Innate Pharma SA | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -56.33% |
| Return on Assets | -18.56% |
| Return on Invested Capital | -33.58% |
| Gross Profit Margin (Quarterly) | 37.79% |
| Operating Margin (Quarterly) | -59.50% |
| Return on Net Operating Assets | -30.01% |